Coronary heart disease review

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

Among African Americans without diabetes, the hazard ratio for CHD associated with high GI (per 5-unit increase) was 1.16, but did not reach statistical significance.

Effect: null; HR 1.16

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD